Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP

Rhinology. 2022 Dec 1;60(6):474-478. doi: 10.4193/Rhin22.053.

Abstract

Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Humans
  • Quality of Life*

Substances

  • mepolizumab
  • Antibodies, Monoclonal, Humanized